Alhuraiji A, Alshemmari S, Hamadah A, Jain N, et al. Venetoclax consolidation deepens response and enables measurable residual disease-guided finite therapy in BTK inhibitor-treated chronic lymphocytic leukemia. Leuk Lymphoma 2026 Oct 1:1-6. doi: 10.1080/10428194.2026.2741763.
PMID: 42822838